SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-21-004093
Filing Date
2021-01-25
Accepted
2021-01-25 17:27:38
Documents
8
Period of Report
2021-01-25

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea133874-6k_therapix.htm 6-K 13182
2 NOTICE AND PROXY STATEMENT FOR THE SPECIAL GENERAL MEETING TO BE HELD ON MARCH 1 ea133874ex99-1_therapix.htm EX-99.1 335728
3 PROXY CARD FOR THE SPECIAL GENERAL MEETING TO BE HELD ON MARCH 1, 2021 ea133874ex99-2_therapix.htm EX-99.2 20132
4 VOTING INSTRUCTION CARD FOR THE SPECIAL GENERAL MEETING TO BE HELD ON MARCH 1, 2 ea133874ex99-3_therapix.htm EX-99.3 1335
5 GRAPHIC ex99-1_001.jpg GRAPHIC 10475
6 GRAPHIC ex99-2_001.jpg GRAPHIC 10453
7 GRAPHIC image_001.jpg GRAPHIC 62250
8 GRAPHIC image_002.jpg GRAPHIC 55194
  Complete submission text file 0001213900-21-004093.txt   562462
Mailing Address 16 ABBA HILLEL ROAD RAMAT GAN L3 5250608
Business Address 16 ABBA HILLEL ROAD RAMAT GAN L3 5250608 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38041 | Film No.: 21550870
SIC: 2834 Pharmaceutical Preparations